Bert Cruys
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Ubiquitin and proteasome pathways 1
-
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Peter Carmeliet (4 shared papers)Guy Eelen (2 shared papers)Katie Bentley (3 shared papers)Saar Vandekeere (2 shared papers)Mieke Dewerchin (2 shared papers)Stefan Vinckier (2 shared papers)Laura Bierhansl (1 shared paper)Ulrike Brüning (1 shared paper)
- Journals
- Nature Communications (1 paper)The EMBO Journal (1 paper)Development (1 paper)Trends in Endocrinology and Metabolism (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- BelgiumUnited StatesSweden
In The Last Decade
Bert Cruys
10 papers receiving 550 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 216
- Biochemistry 39
- Molecular Biology 312
- Cell Biology 61
- Modeling and Simulation 17
Countries citing papers authored by Bert Cruys
This map shows the geographic impact of Bert Cruys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Cruys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Cruys more than expected).
Fields of papers citing papers by Bert Cruys
This network shows the impact of papers produced by Bert Cruys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Cruys. The network helps show where Bert Cruys may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Cruys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 238 | |
| 2 | 2016 | 140 | |
| 3 | 2018 | 56 | |
| 4 | 2013 | 54 | |
| 5 | 2013 | 25 | |
| 6 | 2022 | 17 | |
| 7 | 2022 | 14 | |
| 8 | 2017 | 7 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 1 |
About Bert Cruys
Bert Cruys is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Surgery, having authored 10 papers that have together received 553 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Acute Myeloid Leukemia Research (1 paper), Genomics and Rare Diseases (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (216 citations), Biochemistry (39 citations), Molecular Biology (312 citations), Cell Biology (61 citations) and Modeling and Simulation (17 citations). Bert Cruys has collaborated with scholars based in Belgium, United States and Sweden. Frequent co-authors include Peter Carmeliet, Guy Eelen, Katie Bentley, Saar Vandekeere, Mieke Dewerchin, Stefan Vinckier, Laura Bierhansl, Ulrike Brüning, Bart Ghesquière and Annalisa Zecchin. Their work appears in journals such as Nature Communications, The EMBO Journal, Development, Trends in Endocrinology and Metabolism and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.